FRONTLINE^® becomes Brand of the Year 2021-2022 in World Branding Awards

Ingelheim, Germany, September 13, 2021 – Boehringer Ingelheim, a global leader in animal health, is proud to announce that its FRONTLINE^® brand was named global Brand of the Year 2021-2022 in the Animalis Edition of the World Branding Awards.

The organizer of the World Branding Awards, World Branding Forum, headquartered in London, UK, is a global non-profit organization dedicated to advancing branding standards for the good of the branding community as well as consumers. It organizes and sponsors a range of educational programs, including collaborations with leading universities and museums.

The winners are judged through three streams: brand valuation, consumer market research and public online voting. Over 115,000 pet and animal lovers from around the world voted for their favorite brands, in 41 countries, across six continents. This year, more than 1,100 brands were nominated by the public but only 150 were named “Brand of the Year”.

“This is a celebration of the best marketers of pet and animal brands from across the globe. As consumer votes constitute 70 percent of the final score, winners of the Awards must have strong brand recall amongst their consumers,” explains Richard Rowles, Chairman, World Branding Forum.

Michael Horn, Global Head of Pet Parasiticides, shares: “We are absolutely delighted to have won this global Award again. It recognizes our teams who work tirelessly ensuring brand awareness is high and consumers know what our brands stand for in the ever-changing pet segment and animal health industry.”

World Branding Forum

The World Branding Forum (WBF) is a global, non-profit organization dedicated to advancing branding standards for the good of the branding community as well as consumers. This includes those who work in the branding, design, marketing, advertising, public relations and communications disciplines worldwide. The WBF produces, manages and supports a wide range of programs covering research, development, education, recognition, networking and outreach. For more information visit www.brandingforum.org

Boehringer Ingelheim Animal Health

The lives of animals and humans are interconnected in deep and complex ways. We know that when animals are healthy, humans are healthier too. Across the globe, our 9,700 employees are dedicated to delivering value through innovation, thus enhancing the well-being of both.

Respect for animals, humans and the environment is at the heart of what we do. We develop solutions and provide services to protect animals from disease and pain. We support our customers in taking care of the health of their animals and protect our communities against life- and society-threatening diseases.

Boehringer Ingelheim Animal Health is the second largest animal health business in the world, with net sales of 4.1 billion euros in 2020 and presence in more than 150 countries. For more information visit: www.boehringer-ingelheim.com/animal-health/overview

Boehringer Ingelheim

Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Around 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Learn more at www.boehringer-ingelheim.com

Intended audiences:

This press release is issued from our Corporate Headquarters in Ingelheim, Germany and is intended to provide information about our global business. Please be aware that information relating to the approval status and labels of approved products may vary from country to country, and a country-specific press release on this topic may have been issued in the countries where we do business.